Home > Boards > US Listed > Biotechs > Geron Corp. (GERN)

News: $GERN Why International Regulations On Clinical Trials

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 25
Posts 3,396
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress GlobeNewswire Inc. - 6/17/2019 8:20:00 AM
Geron to Webcast KOL Event on June 25, 2019 GlobeNewswire Inc. - 6/10/2019 4:45:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:26:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:25:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:24:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:24:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:23:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:19:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 5:22:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 9:26:22 AM
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress GlobeNewswire Inc. - 5/16/2019 9:05:49 AM
Geron Provides Imetelstat Program Update GlobeNewswire Inc. - 5/16/2019 8:00:00 AM
Geron Continues to Build Senior Leadership of Its Development Team GlobeNewswire Inc. - 5/16/2019 6:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/3/2019 2:33:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 4:18:03 PM
Geron Corporation Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/2/2019 4:17:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2019 4:09:48 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/22/2019 5:16:27 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/22/2019 5:11:37 PM
Geron Expands Senior Leadership of Its Development Team GlobeNewswire Inc. - 4/18/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/10/2019 7:46:59 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/8/2019 5:17:32 PM
Geron to Present at Needham Healthcare Conference GlobeNewswire Inc. - 4/2/2019 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/28/2019 8:31:56 AM
Geron Appoints Two New Independent Board Members GlobeNewswire Inc. - 3/28/2019 8:00:00 AM
whytestocks Member Level  Thursday, 04/11/19 08:30:56 AM
Re: None
Post # of 6765 
News: $GERN Why International Regulations On Clinical Trials Can Actually Reduce Costs And Shorten Time To Market

April 11, 2019 Palm Beach, FL – April 11, 2019 – Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the biotechnology industry as well. Usually regulations increase costs and create ...

Find out more https://marketwirenews.com/news-releases/why-international-regulations-on-clinical-trials-can-actually-reduce-costs-and-shorten-time-to-market-7984080.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist